EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma

Maxine Sy Lam iD, Joey Jy Aw, Damien Tan, Ragavi Vijayakumar, Hui Yi Grace Lim, Swathi Yada, Qing You Pang, Nick Barker, Carol Tang, Beng Ti Ang, Radoslaw M Sobota, Andrea Pavesi iD

Small · 2023

DOI: 10.1002/smll.202302280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2023. Verfasst von Maxine Sy Lam und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Singapore, 138673, Singapore. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: A*STAR Career Development Fund, Singapore Ministry of Health's National Medical Research Council, Clinician Scientist - Individual Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most common primary malignant brain cancer in adults with a dismal prognosis. Temozolomide (TMZ) is the first‐in‐line chemotherapeutic; however, resistance is frequent and multifactorial. While many molecular and genetic factors have been linked to TMZ resistance, the role of the solid tumor morphology and the tumor microenvironment, particularly the blood‐brain barrier (BBB), is unknown. Here, the authors investigate these using a complex in vitro model for GBM and its surrounding BBB. The model recapitulates important clinical features such as a dense tumor core with tumor cells that invade along the perivascular space; and a perfusable BBB with a physiological permeability and morphology that is altered in the presence of a tumor spheroid. It is demonstrated that TMZ sensitivity decreases with increasing cancer cell spatial organization, and that the BBB can contribute to TMZ resistance. Proteomic analysis with next‐generation low volume sample workflows of these cultured microtissues revealed potential clinically relevant proteins involved in tumor aggressiveness and TMZ resistance, demonstrating the utility of complex in vitro models for interrogating the tumor microenvironment and therapy validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsHumansTemozolomideBlood-Brain BarrierTumor MicroenvironmentProteomicsDrug Resistance, NeoplasmCell Line, TumorXenograft Model Antitumor Assays

Stichwörter der Autor:innen

blood-brain barrierchemoresistancedia-PASEFglioblastomamicrofluidic modelsspatial heterogeneity

Substanzen

Temozolomide

Autor:innen und Institutionen

  • Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Singapore, 138673, Singapore.
  • Functional Proteomics Laboratory, SingMass National Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Singapore, 138673, Singapore.
  • Neuro-Oncology Research Laboratory, Department of Research, National Neuroscience Institute, Singapore, 308433, Singapore.
  • Duke-National University of Singapore Medical School, Singapore, 169857, Singapore.
  • School of Biological Sciences, Nanyang Technological University, Singapore, 637551, Singapore.
  • Department of Neurosurgery, National Neuroscience Institute, Singapore, 308433, Singapore.

ORCID-Profile: Maxine Sy Lam, Andrea Pavesi

Förderung

  • A*STAR Career Development Fund
  • Singapore Ministry of Health's National Medical Research Council
  • Clinician Scientist - Individual Research
  • Open Fund-Large Collaborative
  • A.P., N.B. and R.M.S. are supported by A*STAR Core funding

Zitieren

APA

Lam, M. S., Aw, J. J., Tan, D., Vijayakumar, R., Lim, H. Y. G., Yada, S., Pang, Q. Y., Barker, N., Tang, C., Ang, B. T., Sobota, R. M., & Pavesi, A. (2023). Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma. Small. https://doi.org/10.1002/smll.202302280

Vancouver

Lam MS, Aw JJ, Tan D, Vijayakumar R, Lim HYG, Yada S, et al. Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma. Small. 2023. doi:10.1002/smll.202302280

BibTeX
@article{Lam2023,
  author = {Lam, Maxine Sy and Aw, Joey Jy and Tan, Damien and Vijayakumar, Ragavi and Lim, Hui Yi Grace and Yada, Swathi and Pang, Qing You and Barker, Nick and Tang, Carol and Ang, Beng Ti and Sobota, Radoslaw M and Pavesi, Andrea},
  title = {Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma},
  journal = {Small},
  year = {2023},
  doi = {10.1002/smll.202302280}
}
Kostenlos starten →